S.R. Drugs And Intermediates Pvt.Ltd. - Company Profile

It is a chemicals and materials private limited company based in Hyderabad, Telangana, India, established in 1992.
1992 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About S.R. Drugs And Intermediates Pvt.Ltd.

S.R. Drugs And Intermediates Pvt.Ltd., a active private limited company, was established on 20 October 1992 in Hyderabad, Telangana, India. Engaging in specialty chemicals within the manufacturing sector, it holds CIN: U24230TG1992PTC014907. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹2.60 Cr.

It upholds a compliant status. Its leadership includes Satyanarayana Reddy Khairtabad (Whole-Time Director), Hemalatha Chinnamail (Whole-Time Director), Sharada Khairatabad (Whole-Time Director). Past directors included Satyanarayana Reddy Khairtabad, Hemalatha Chinnamail, Sharada Khairatabad. It holds ₹134.69 Cr open charges and ₹2.08 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at H.No. 3-58, S.R.Chambers, Main Road, Ramachandrapum, Hyderabad, Telangana, 502032.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230TG1992PTC014907

  • Registration Number

    014907

  • Incorporation Date

    20 October 1992

  • Authorized Capital

    ₹3.00 Cr

  • Paid-Up Capital

    ₹2.60 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.00 Cr
  • Paid Up Capital ₹ 2.60 Cr
  • Company Age 33 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 134.69 Cr
  • Satisfied Charges ₹ 2.08 Cr
  • Revenue Growth **** 2.60%
  • Profit Growth **** 53.74%
  • Ebitda **** 48.30%
  • Net Worth 19.56%
  • Total Assets **** 12.30%
Company report

S.R. Drugs And Intermediates Pvt.Ltd.

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into S.R. Drugs And Intermediates Pvt.Ltd. — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at S.R. Drugs And Intermediates Pvt.Ltd.?
Current Directors
Name Designation Appointment Date Status
Satyanarayana Reddy Khairtabad Whole-Time Director 12 Nov 1997 Current
Hemalatha Chinnamail Whole-Time Director 24 Dec 2002 Current
Sharada Khairatabad Whole-Time Director 24 Dec 2002 Current
Satyanarayana Reddy Chinnamail Managing Director 22 Oct 1992 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Oct 2018 Past
Pramod Abcsdd Director 01 Oct 2018 Past
Pramod Abcsdd Director 01 Oct 2018 Past
Pramod Abcsdd Director 01 Oct 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of S.R. Drugs And Intermediates.Ltd..

S.R. Drugs And Intermediates Pvt.Ltd., for the financial year ended 2023, experienced modest growth in revenue, with a 2.6% increase. The company also saw a substantial improvement in profitability, with a 53.74% increase in profit. The company's net worth Soared by an impressive increase of 19.56%.

S.R. Drugs And Intermediates.Ltd. revenue growth over time
S.R. Drugs And Intermediates.Ltd. profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 2.60%
*******
*******
*******
*******
Revenue from Operations
*******
 1.04%
*******
*******
*******
*******
Total Assets
*******
 12.30%
*******
*******
*******
*******
Profit or Loss
*******
 53.74%
*******
*******
*******
*******
Net Worth
*******
 19.56%
*******
*******
*******
*******
EBITDA
*******
 48.30%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of S.R. Drugs And Intermediates.Ltd.?

In 2023, S.R. Drugs And Intermediates.Ltd. had a promoter holding of 100.00%. The company had 1 Subsidiary and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹1,346,858,750.00

Satisfied Charges

₹20,822,000.00

Charges Breakdown by Lending Institutions
  • Karnataka Bank Ltd. : 108.62 Cr
  • Others : 26.00 Cr
  • Andhra Pradesh State Financial Corporation : 0.07 Cr
Latest Charge Details
Date Lender Amount Status
18 Oct 2022 Karnataka Bank Ltd. ₹2.96 M Open
11 Jan 2022 Karnataka Bank Ltd. ₹1.72 Cr Open
30 Dec 2021 Karnataka Bank Ltd. ₹8.90 Cr Open
03 Sep 2020 Karnataka Bank Ltd. ₹2.72 Cr Open
27 May 2020 Others ₹26.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at S.R. Drugs And Intermediates.Ltd.?

Unlock and access historical data on people associated with S.R. Drugs And Intermediates.Ltd., such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of S.R. Drugs And Intermediates.Ltd., offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped S.R. Drugs And Intermediates.Ltd.'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on S.R. Drugs And Intermediates.Ltd.
Recent Activity within the Organization
  • Charges

    Progress on A charge registered on 20 Jun 2020 via Charge ID 100350055 with Karnataka Bank Ltd. was fully satisfied on 04 Nov 2025. was documented.

  • Annual General Meeting

    Progress on S.R. Drugs And Intermediates Pvt.Ltd. last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on S.R. Drugs And Intermediates Pvt.Ltd. has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.

  • Charges

    The activity A charge with Karnataka Bank Ltd. of Rs. 22.24 Cr registered on 27 Nov 2000 with Charge ID 90124207 was modified on 25 Mar 2025. was completed.

  • Charges

    The activity A charge with Karnataka Bank Ltd. amounted to Rs. 0.30 Cr with Charge ID 100629159 was registered on 18 Oct 2022. was completed.

  • Charges

    Progress on A charge with Karnataka Bank Ltd. amounted to Rs. 1.72 Cr with Charge ID 100541694 was registered on 11 Jan 2022. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of S.R. Drugs And Intermediates Pvt.Ltd.?

The CIN of S.R. Drugs And Intermediates Pvt.Ltd. is U24230TG1992PTC014907.

Where is S.R. Drugs And Intermediates Pvt.Ltd. headquartered?

S.R. Drugs And Intermediates Pvt.Ltd. is headquartered at H.No. 3-58, S.R.Chambers, Main Road, Ramachandrapum, Hyderabad, Telangana, 502032.

When was S.R. Drugs And Intermediates Pvt.Ltd. incorporated?

S.R. Drugs And Intermediates Pvt.Ltd. was incorporated on 20 October 1992.

Who are the current directors of S.R. Drugs And Intermediates Pvt.Ltd.?

The current directors of S.R. Drugs And Intermediates Pvt.Ltd. are

What is the primary industry of S.R. Drugs And Intermediates Pvt.Ltd.?

The primary industry of S.R. Drugs And Intermediates Pvt.Ltd. is Manufacturing.

Is S.R. Drugs And Intermediates Pvt.Ltd. a listed company?

S.R. Drugs And Intermediates Pvt.Ltd. is unlisted.

What is the capital structure of S.R. Drugs And Intermediates Pvt.Ltd.?

The authorized capital of S.R. Drugs And Intermediates Pvt.Ltd. is ₹3.00 Cr, and the paid-up capital is ₹2.60 Cr.

What is the compliance status of S.R. Drugs And Intermediates Pvt.Ltd.?

The compliance status of S.R. Drugs And Intermediates Pvt.Ltd. is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available